Antipsychotic Trials in Schizophrenia: The CATIE Project
Editat de T. Scott Stroup, Jeffrey A. Liebermanen Limba Engleză Hardback – 31 mar 2010
Preț: 837.71 lei
Preț vechi: 881.80 lei
-5% Nou
Puncte Express: 1257
Preț estimativ în valută:
160.31€ • 166.35$ • 133.99£
160.31€ • 166.35$ • 133.99£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780521895330
ISBN-10: 0521895332
Pagini: 330
Ilustrații: 50 b/w illus.
Dimensiuni: 20 x 240 x 161 mm
Greutate: 0.7 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:Cambridge, United Kingdom
ISBN-10: 0521895332
Pagini: 330
Ilustrații: 50 b/w illus.
Dimensiuni: 20 x 240 x 161 mm
Greutate: 0.7 kg
Editura: Cambridge University Press
Colecția Cambridge University Press
Locul publicării:Cambridge, United Kingdom
Cuprins
List of contributors; Acknowledgements; Introduction; 1. Study design and protocol development process T. Scott Stroup, Joseph P. McEvoy and Jeffrey A. Lieberman; 2. Statistical considerations Sonia M. Davis, Gary G. Koch, Robert A. Rosenheck and Vicki G. Davis; 3. Effectiveness and efficacy: staying on treatment and symptom reduction Joseph P. McEvoy, T. Scott Stroup and Jeffrey A. Lieberman; 4. Cost-effectiveness and cost-benefit analysis Robert A. Rosenheck and Douglas L. Leslie; 5. Psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study Marvin S. Swartz; 6. Neurocognition Richard S. E. Keefe; 7. Vocational outcomes Sandra G. Resnick and Robert A. Rosenheck; 8. Family outcomes Deborah A. Perlick, Richard Kaczynski and Robert A. Rosenheck; 9. Extrapyramidal side effects Stanley N. Caroff, Del D. Miller and Robert A. Rosenheck; 10. Metabolic side effects and risk of cardiovascular disease Jonathan M. Meyer, Donald C. Goff and Joseph P. McEvoy; 11. Substance use in persons with schizophrenia: incidence, baseline correlates, and effects on outcome Fred Reimherr, Marvin S. Swartz and John L. Olsen; 12. Violence in schizophrenia: prevalence, correlates, and treatment effectiveness Jeffrey Swanson and Richard Van Dorn; 13. Genetic investigations in the CATIE sample James J. Crowley and Patrick F. Sullivan; 14. Human subjects considerations T. Scott Stroup and Paul Appelbaum; 15. Population pharmacokinetics of antipsychotics Kristin L. Bigos, Robert R. Bies, Stephen R. Marder and Bruce G. Pollock; 16. Implications for research design and study implementation T. Scott Stroup and Jeffrey A. Lieberman; 17. Conclusion and implications for practice and policy Robert A. Rosenheck, T. Scott Stroup and Jeffrey A. Lieberman.
Recenzii
'… important and timely …' Doody's
'This book is not just a reprint of all published CATIE papers - it takes us beyond the hype of the first publication by reminding us of the breadth and depth of the trial … This book will be of major interest to anyone involved in psychopharmacology. However, the richness of the use of social and cognitive end points means that there is a wealth of information for those who have no interest in antipsychotics but are interested in the lives and outcomes of people with schizophrenia.' The British Journal of Psychiatry
'This book is not just a reprint of all published CATIE papers - it takes us beyond the hype of the first publication by reminding us of the breadth and depth of the trial … This book will be of major interest to anyone involved in psychopharmacology. However, the richness of the use of social and cognitive end points means that there is a wealth of information for those who have no interest in antipsychotics but are interested in the lives and outcomes of people with schizophrenia.' The British Journal of Psychiatry
Descriere
This book presents the results of the landmark CATIE study, a long and comprehensive study of schizophrenia.